PERSPECTA

News from every angle

← Back to headlines

BridgeBio Oncology Therapeutics Reports GAAP EPS of -$526.11

BridgeBio Oncology Therapeutics, Inc. has reported a GAAP EPS of -$526.11 for its latest financial period.

12 May, 21:12 — 12 May, 21:12
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed111d ago

BridgeBio Oncology Therapeutics, Inc. GAAP EPS of -$526.11

Read full article →

Related Stories

U.S. Strikes on Iran Push Crude Oil Prices Above $90 a Barrel

27m ago

Shein Prices Hong Kong IPO Below Top End, Raising $1.74 Billion

1h ago

Trump Administration Advances Venezuela Oil Talks and Drug Pricing Deals

1h ago

Wall Street Opens Lower as Middle East Tensions Drive Up Oil Prices

1h ago